van den Hout W B, van den Brink M, Stiggelbout A M, van de Velde C J H, Kievit J
Department of Medical Decision Making, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands.
Eur J Cancer. 2002 May;38(7):953-63. doi: 10.1016/s0959-8049(02)00053-9.
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health.
本文简要概述了成本效益分析方法，随后对已发表的结直肠癌治疗成本效益分析进行了综述。为了提高可信度，成本效益分析中应用的方法必须进一步改进。成本很少从社会角度进行估计，而且对于结直肠癌患者如何评估其治疗和健康状况知之甚少。
